My ePortfolio Register   

WIN Symposium 2017 /
Biomarker research in breast cancer

26th - 27th Jun 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.07.17
Views: 840

Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium

Prof Piccart speaks with ecancer at WIN 2017 about issues facing translational research, and the need to look beyond individual biomarkers to characterise a whole-cell understanding on cancer.

She outlines her priorities in determining how chemotherapy regimens could be reduced or phased out entirely with immune therapies, and considers how ongoing surveillance of tumour genomics may offer immediate insight into treatment response.

The clinical utility of serial biopsies was also discussed by Dr Daniel Hayes, here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence